National Bank Of Canada Fsd Pharma Inc. Transaction History

National Bank Of Canada

  • $72.7 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023
SELL
$0.99 - $2.04 $5 - $12
-6 Reduced 0.83%
716 $0
Q4 2021

Jan 24, 2022
BUY
$0.96 - $1.63 $693 - $1,176
722 New
722 $1,000

About FSD Pharma Inc.

HUGE Quotes by TradingView
  • Ticker HUGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 38,218,100
  • Market Cap $146M
  • Description
  • FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...
More about HUGE
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email